MedBodh Clinical Drug Preparation | Updated 4 November 2026. Professional reference; verify local brand-specific prescribing information and hospital protocol before bedside administration.
CLINICAL SAFETY NOTICE (5 Nov 2026): Educational overview only, not a validated bedside preparation chart. Verify exact dose, dilution, rate, compatibility, stability, renal/hepatic adjustments and paediatric use against the specific product label, current institutional protocol and pharmacist. Do not infer dosing from this page alone.
Clinical indications and strengths
Sodium bicarbonate 8.4% is a hypertonic IV solution. It contains 84 mg/mL sodium bicarbonate, equivalent to 1 mEq/mL of sodium and bicarbonate: a 10 mL ampoule therefore contains 10 mEq. It is not routinely indicated for every cardiac arrest or metabolic acidosis. Use only after evaluating the clinical indication, blood gas, ventilation, sodium and potassium.
Preparation and administration workflow
- Verify patient identity, indication, allergy history, body weight where applicable and prescriber’s order.
- Read actual vial/bag concentration and distinguish salt strength from active-base equivalent where relevant.
- Check manufacturer-authorised diluent, final concentration, compatibility, route, infusion pump and beyond-use time.
- Perform independent high-alert medication double-check and label every prepared syringe/bag.
- Document preparation, administration, monitoring and any adverse reaction.
Emergency safety, nursing monitoring and special populations
The product is for intravenous use under medical supervision. Concentration and dilution requirements vary by indication and patient age; neonates and young children require particular caution. Do not add calcium-containing solutions: precipitation may occur. Norepinephrine and dobutamine are incompatible with bicarbonate solution in the cited label. Monitor serial blood gases, electrolytes, volume status and IV site; watch for alkalosis, hypernatraemia, hypokalaemia and extravasation. Verify local product instructions before use.
Adult and paediatric dosing
There is no single safe universal dose: dosing varies by indication, age/weight, organ function, formulation and clinical response. Use the linked full product label and the current hospital emergency algorithm rather than extrapolating one preparation to every scenario.
Contraindications, interactions and common errors
Review the product-specific label, comorbidities, concurrent medicines and IV compatibility. Do not mix drugs in the same line without verified compatibility. Escalate immediately for suspected medication error or adverse drug reaction.
Primary manufacturer label
DailyMed: current official product labelling. Indian brands can differ in concentration, excipients and authorised routes; verify the locally stocked ampoule.